An Integrative Multiomics Framework for Identification of Therapeutic Targets in Pulmonary Fibrosis

Pulmonary fibrosis (PF) is a heterogeneous disease with a poor prognosis. Therefore, identifying additional therapeutic modalities is required to improve outcome. However, the lack of biomarkers of disease progression hampers the preclinical to clinical translational process. Here, this work assesse...

Descripción completa

Detalles Bibliográficos
Autores principales: Arif, Muhammad, Basu, Abhishek, Wolf, Kaelin M., Park, Joshua K., Pommerolle, Lenny, Behee, Madeline, Gochuico, Bernadette R., Cinar, Resat
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10238219/
https://www.ncbi.nlm.nih.gov/pubmed/37038090
http://dx.doi.org/10.1002/advs.202207454

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10238219/
https://www.ncbi.nlm.nih.gov/pubmed/37038090
http://dx.doi.org/10.1002/advs.202207454

Ejemplares similares